Physician profile
Lynn A Van Epps
NPI 1073942660
$490.30
in general payments reported to CMS, 2019-2025
11 companies · $33.35 in 2025
The $33.35 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.21 · 2022: $55.60 · 2023: $165 · 2024: $202 · 2025: $33.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $112.42 | 2024-2025 | |
| Pfizer INC. | $103.55 | 2021-2024 | |
| Amgen INC. | $79.85 | 2023-2024 | Repatha, Otezla, Krystexxa |
| Glaxosmithkline, LLC. | $52.25 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $45.40 | 2022-2023 | |
| Fidia Pharma USA INC. | $20.02 | 2024 | Hyalgan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.36 | 2023 | Jardiance |
| Novo Nordisk INC | $17.84 | 2021 | |
| Exact Sciences Corporation | $13.48 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $13.26 | 2022 | |
| Lilly USA, LLC | $12.87 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Van Epps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.